Cargando…
Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition
Inhibition of epidermal growth factor receptor (EGFR) signaling has emerged as a novel therapeutic strategy for the treatment of oral squamous cell carcinoma (OSCC). The EGFR-directed inhibitor cetuximab is currently the only approved targeted therapy for the treatment of OSCC. EGFR status may affec...
Autores principales: | KIMURA, IYO, KITAHARA, HIROKO, OOI, KAZUHIRO, KATO, KOROKU, NOGUCHI, NATUYO, YOSHIZAWA, KUNIO, NAKAMURA, HIROYUKI, KAWASHIRI, SHUICHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727181/ https://www.ncbi.nlm.nih.gov/pubmed/26870189 http://dx.doi.org/10.3892/ol.2015.3833 |
Ejemplares similares
-
Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition
por: Kitahara, Hiroko, et al.
Publicado: (2016) -
Clinicopathological Significance of the ET Axis in Human Oral Squamous Cell Carcinoma
por: Miyazawa, Hiroki, et al.
Publicado: (2018) -
Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
por: Hirai, Mariko, et al.
Publicado: (2016) -
The pattern and spread of invasion can predict late cervical lymph node metastasis in early tongue squamous cell carcinoma
por: Kato, Koroku, et al.
Publicado: (2023) -
Tumour: Fibroblast Interactions Promote Invadopodia-Mediated Migration and Invasion in Oral Squamous Cell Carcinoma
por: Kato, Koroku, et al.
Publicado: (2022)